Domov › Nemalicelični pljučni rak › Distrikta Columbia › Washington
Klinične študije za Nemalicelični pljučni rak v Washington, DC
55 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- in še 1
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- Local Institution - 0183, Washington D.C.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Vključevanje udeležencevFaza 3
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of PHN-012 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- PHN-012-001 Site, Washington D.C.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi stran
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi stran
- Maryland Oncology Hematology, P.A, Largo · 11 mi stran
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Silver Spring · 7 mi stran
- Research Site, Bethesda · 7 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi stran
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi stran
- Maryland Oncology Hematology, P.A., Largo · 11 mi stran
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- MedStar Georgetown University Hospital, Washington D.C.
- Washington DC VA Medical Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7 mi stran
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Vključevanje udeležencevFaza 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Vključevanje udeležencevFaza 2
- MedStar Georgetown University Hospital, Washington D.C.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Vključevanje udeležencevFaza 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Georgetown University Medical Center, Washington D.C.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- Research Site, Bethesda · 7 mi stran
- Research Site, Bethesda · 7 mi stran
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Vključevanje udeležencevFaza 3
- George Washington University Cancer Center, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Vključevanje udeležencevFaza 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Local Institution - 007-5476, Washington D.C.
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Vključevanje udeležencevFaza 3
- Washington Hospital Center ( Site 0037), Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Bethesda · 7 mi stran
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- MedStar Georgetown University Hospital, Washington D.C.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- National Institutes of Health, Bethesda · 7 mi stran
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 1/2
- Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Vključevanje udeležencevFaza 1/2
- Georgetown University Medical Center, Washington D.C.
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Vključevanje udeležencevFaza 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Vključevanje udeležencevFaza 1/2
- Georgetown University, Washington D.C.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 1
- Maryland Oncology Hematology, Calverton · 12 mi stran
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
Vključevanje udeležencevFaza 1
- Georgetown University, Washington D.C.
Study of XB010 in Subjects With Solid Tumors
Vključevanje udeležencevFaza 1
- Georgetown University Medical Center, Washington D.C.
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi stran
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- USA11-0, Bethesda · 7 mi stran
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Vključevanje udeležencevFaza 3
- Georgetown University Medical Cener (GUMC), Washington D.C.
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Washington D.C.
- Research Site, Bethesda · 7 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi stran
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Vključevanje udeležencevFaza 1/2
- Sibley Memorial Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- National Cancer Institute, Bethesda · 7 mi stran
Repositioning Immunotherapy in VetArans With Lung Cancer
Vključevanje udeležencevFaza 2
- VA Central Office, Washington, DC, Washington D.C.
GEMINI-NSCLC: NSCLC Biomarker Study
Vključevanje udeležencevOpazovalna študija
- The Center for Cancer and Blood Disorder, Bethesda · 7 mi stran
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Vključevanje udeležencevFaza 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi stran
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi stran
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Vključevanje udeležencevFaza 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Seattle, WA53 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Rak dojke46 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Akutna mieločna levkemija24 študij
- Rak jajčnikov23 študij
- Limfom23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.